Avastin Lung Cancer
Genentech (South San Francisco, CA) and Osi (Melville, NY) received positive initial results in a Phase I/II trial of anticancer drugs Avastin (bevacizumab) / Tarceva (erlotinib HCl) in non-small cell lung cancer.(Phase I/II) Genentech (South San Francisco, CA) and Osi (Melville, NY) received positive initial results in a Phase I/II trial of anticancer ...
|
